{"id":40156,"date":"2017-08-17T08:01:58","date_gmt":"2017-08-17T12:01:58","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=40156"},"modified":"2017-08-17T05:37:46","modified_gmt":"2017-08-17T09:37:46","slug":"bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156","title":{"rendered":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer"},"content":{"rendered":"<p><strong>Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)<\/strong> reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy and business development for the firm.<\/p>\n<h2><strong>The details<\/strong><\/h2>\n<p>Rick Fair, the CEO and President of Bellicum, reported that they are thrilled to welcome a leader of Dr. Naeve\u2019s caliber and experience as they intend to expand their pipeline and seek strategic associations to leverage their technology platform. Dr. Naeve brings a remarkable track record of outlining immuno-oncology portfolio strategy and executing it through successful alliances. His contributions will be significant as they look to capitalize on their portfolio of controllable cell therapy technologies.<\/p>\n<p>Commenting on his new role, Dr. Naeve expressed that it is becoming gradually clear how vital innovations are to advancing TCR and CAR T candidates into more ailments, especially solid tumors. He will work together with Bellicum\u2019s R&amp;D and management teams to advance these innovative technologies, which possesses potential to transform the world of cellular therapy.<\/p>\n<p>Prior to Bellicum, Dr. Naeve was associated with <strong>Pfizer Inc. (NYSE:PFE)<\/strong> where he was as the ImmunoOncology and Cell Therapy Lead for company\u2019s External Research and Development segment.<\/p>\n<p>During his tenure, he was a member of the executive team responsible for recognizing and implementing numerous strategic associations in Pfizer\u2019s ImmunoOncology portfolio. Prior to Pfizer, Dr. Naeve was a Principal of \u201cThe Column Group\u201d, which is a venture capital company focused on investing in and building unique biotechnology firms. Early in his career, he served on research roles at Amgen and Neurocrine Biosciences.<\/p>\n<p>The Compensation Committee of Bellicum\u2019s Board has permitted inducement awards to Dr. Naeve, effective from the joining date. These inducement awards comprise of a stock option to buy up to 130,000 shares of the firm\u2019s common stock as well as a restricted stock unit in lieu for 15,000 shares.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":40163,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12838,11448,12837,358,11449,12413,993,207,2745,3275],"stock_ticker":[],"class_list":["post-40156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-bellicum-pharmaceuticals-inc","tag-bellicum-pharmaceuticals-inc-nasdaqblcm","tag-blcm","tag-nasdaq","tag-nasdaqblcm","tag-nyse","tag-nysepfe","tag-pfe","tag-pfizer-inc-nysepfe","tag-pfizer-inc","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-17T12:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"5120\" \/>\n\t<meta property=\"og:image:height\" content=\"3413\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer\",\"datePublished\":\"2017-08-17T12:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\"},\"wordCount\":326,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg\",\"keywords\":[\"Bellicum Pharmaceuticals Inc\",\"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)\",\"BLCM\",\"NASDAQ\",\"NASDAQ:BLCM\",\"NYSE\",\"NYSE:PFE\",\"PFE\",\"Pfizer Inc (NYSE:PFE)\",\"Pfizer Inc.\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\",\"name\":\"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg\",\"datePublished\":\"2017-08-17T12:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg\",\"width\":5120,\"height\":3413},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156","og_locale":"en_US","og_type":"article","og_title":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer - Wall Street PR","og_description":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-08-17T12:01:58+00:00","og_image":[{"width":5120,"height":3413,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer","datePublished":"2017-08-17T12:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156"},"wordCount":326,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg","keywords":["Bellicum Pharmaceuticals Inc","Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)","BLCM","NASDAQ","NASDAQ:BLCM","NYSE","NYSE:PFE","PFE","Pfizer Inc (NYSE:PFE)","Pfizer Inc."],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156","url":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156","name":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg","datePublished":"2017-08-17T12:01:58+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40162-new-york-wall-street.jpg","width":5120,"height":3413},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bellicum-pharmaceuticals-inc-nasdaqblcm-announces-gregory-naeve-as-chief-business-officer-40156#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=40156"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40156\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/40163"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=40156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=40156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=40156"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=40156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}